IP Library Granted Patent US 10,143,562
Granted Patent B2
US 10,143,562 · App. 14/718,796 · Granted Dec 4, 2018

Vertebral body end-plate microparticulate composition and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,562
App. No.
14/718,796
Granted
Dec 4, 2018
Kind
B2
Abstract

A particulate composition for stimulating nucleus pulposus regeneration has a particulate composition made of vertebral end-plates having an osseous component wherein the composition is milled, ground or particulized into particles from 10 to 1000 microns in size. At least a part of the composition can be non-demineralized or demineralized or a mixture of demineralized and non-demineralized particles from the vertebral end-plates. Preferably, the non-demineralized part is not subjected to harsh chemical treating. To possibly enhance the release of growth factors and other similar substances from the osseous layer of the end-plate, the material may be treated with hydrochloric acid, ethylene diamine or other demineralizing agents or regimens.

Claims (25)

1. A particulate composition for stimulating nucleus pulposus regeneration comprising:

a particulate composition made of cartilaginous end-plates taken from vertebral end-plates having an osseous component or layer wherein the composition is milled or ground into particles from 10 to 1000 microns in size, wherein the cartilaginous end-plates taken from the vertebral end plates include a blend of coarse collagen strands and material for budding notochordal cells.

2. A particulate composition for stimulating nucleus pulposus regeneration comprising:

a particulate composition made of cartilaginous end-plates taken from vertebral end-plates having an osseous component or layer wherein the composition is milled or ground into particles from 10 to 1000 microns in size, wherein the cartilaginous end-plates taken from the vertebral end plates include a blend of coarse collagen strands and material for budding notochordal cells, wherein at least a part of the composition is non-demineralized.

3. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein at least a part of the composition is demineralized.

4. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein the composition is a mixture of demineralized and non-demineralized particles from the vertebral end-plates.

5. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein the composition is preserved by one of freeze-drying, hypothermic dehydration, freezing, chemical classification, storage in glycerol, or saline, or balanced salt solution, or petrolatum.

6. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein the vertebral end-plate is an allograft or a xenograft material.

7. The particulate composition for stimulating nucleus pulposus regeneration of claim 2 wherein the non-demineralized part is not subjected to harsh chemical treating.

8. The particulate composition for stimulating nucleus pulposus regeneration of claim 2 wherein the vertebral end plates are treated with one of hydrochloric acid, ethylene diamine or other demineralizing agents or regimens to enhance a release of growth factors and other similar substances from the osseous component or layer of the vertebral end-plates.

9. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein the end-plate tissue is not subjected to any physical treatments that may alter or denature the material of the composition.

10. The particulate composition for stimulating nucleus pulposus regeneration of claim 9 wherein the end-plate tissue is not subjected to temperatures greater than 70° C., that may diminish the stimulating activity of the end-plate tissue.

11. The particulate composition for stimulating nucleus pulposus regeneration of claim 1 wherein the composition has particles sized between 10 to 800 microns.

12. The particulate composition for stimulating nucleus pulposus regeneration of claim 11 wherein the composition has particles sized between 10 to 500 microns.

13. The particulate composition for stimulating nucleus pulposus regeneration of claim 12 wherein the composition has particles sized between 70 to 300 microns.

14. A method for stimulating generation of the nucleus pulposus comprising:

injecting the particulate composition of claim 1 wherein the composition is milled, ground or particulized into particles from 10 to 1000 microns in size into a damaged disc.

15. The method of claim 14 wherein the step of injecting employs a small bore size cannula to create a small injection hole to permit the damaged disc to close or reseal on withdrawal of the cannula after injection.

16. The method of claim 15 further comprises the step of:

mixing the composition in a sterile solution to facilitate flow prior to injection.

17. The method of claim 16 wherein the sterile solution is one or more of normal saline; water, lactated ringer's solution; balanced salts; or whole blood.

18. The method of claim 14 further comprises the step of:

mixing the composition prior to injection with an amount of collagen or other bioabsorbable material to form an injectable paste of relatively high viscosity to allow injection through a cannula while providing a self-sealing of the hole created by the cannula into the damaged disc.

19. The method of claim 18 further comprises the step of:

withdrawing the cannula from the damaged disc allowing a small portion of injectable paste to at least partially extrude from the hole to close and seal the injection hole in the damaged disc.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
SECURITY INTEREST Recorded Mar 19, 2019
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 048629/0691 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2015
From: MALININ, THEODORE I.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 035692/0356 →